Physician

Abhijeet Ghatol, M.B.B.S.

According to 2025 Medicare claims, Abhijeet Ghatol, M.B.B.S. (NPI: 1598929978) practices pulmonary disease in the Flint, MI market, with the plurality of this provider's patient population coming from Genesee, MI. This provider's primary affiliated billing organization is CHEST AND SLEEP MEDICINE CONSULTANTS,PLC (NPI: 1295811750; TIN: 861176116) and primary practice location at 48532-3638. Ghatol is affiliated with the McLaren High Performance Network, LLC (ACO ID: A3317), participating under the MSSP model.

Ghatol's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 508 traditional Medicare patients, billed 2,351 HCPCS/CPT codes, and received $185,017 in Medicare payments. The top billing code was 99291 (Critical care, first 30-74 minutes). Part D data shows 1,456 prescription claims across 254 beneficiaries totaling $836,991 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). DME data shows 574 claims. Open Payments data shows 17 records totaling $4,451. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $238,912 to $185,017. In contrast, Part D prescription costs have risen steadily, from $39,787 to $836,991. For DME billing, this smaller-volume category rose steadily, from $3,419 to $28,851.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	794	3,110	$238,912
2016	900	3,327	$265,968
2017	975	4,002	$322,933
2018	758	3,103	$238,796
2019	732	3,079	$237,823
2020	669	2,807	$228,258
2021	655	2,995	$238,518
2022	494	2,176	$170,204
2023	483	2,217	$162,713
2024	508	2,351	$185,017

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	99	244	$39,787
2016	157	391	$74,024
2017	219	788	$203,088
2018	283	1,126	$325,141
2019	317	1,446	$501,535
2020	256	1,333	$626,641
2021	245	1,239	$662,870
2022	236	1,067	$571,325
2023	250	1,228	$769,692
2024	254	1,456	$836,991

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	46	$3,092
2016	12	135	$4,563
2017	30	328	$14,452
2018	50	438	$24,826
2019	87	817	$51,452
2020	111	651	$35,603
2021	107	580	$19,234
2022	93	507	$17,183
2023	94	603	$21,896
2024	87	574	$32,199

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99291	Critical care, first 30-74 minutes	97	172	$174
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	123	125	$141
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	202	486	$97
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	207	495	$64
94060	Test to measure expiratory airflow and volume changes before and after medication administration	120	191	$27

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	297	14,040	$287,138
Ofev	Nintedanib Esylate	12	360	$144,106
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	127	5,190	$77,165
Dupixent Pen	Dupilumab	14	392	$50,157
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	46	1,680	$34,796

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	21	149	$9,923
J7677	Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram	N	N/R	12	$9,220
A7030	Full face mask used with positive airway pressure device, each	N	12	28	$2,328
A7031	Face mask interface, replacement for full face mask, each	N	N/R	22	$1,716
J7606	Formoterol fumarate, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 20 micrograms	N	N/R	11	$1,616

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	17	$4,451	INTUITIVE SURGICAL, INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Abhijeet Ghatol, M.B.B.S.?

Tedicare shows public-source Medicare data for Abhijeet Ghatol, M.B.B.S. (NPI 1598929978), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Abhijeet Ghatol, M.B.B.S. have ACO affiliation data?

Abhijeet Ghatol, M.B.B.S. is shown with ACO affiliation data for McLaren High Performance Network, LLC (MSSP, ACO ID A3317).

What billing organization is linked to Abhijeet Ghatol, M.B.B.S.?

Abhijeet Ghatol, M.B.B.S. is linked to CHEST AND SLEEP MEDICINE CONSULTANTS,PLC (billing NPI 1295811750) in the available physician profile data.

Does Abhijeet Ghatol, M.B.B.S. have Open Payments data?

Abhijeet Ghatol, M.B.B.S. has 17 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.